Amgen opens next-gen biomanufacturing facility in Singapore

Skip to Navigation

Blog Post

  • Published: Nov 26, 2014
  • Author: Jon Evans
  • Channels: Gas Chromatography / Ion Chromatography / HPLC / Electrophoresis / Detectors / Laboratory Informatics / Proteomics & Genomics / Sample Preparation

View comments on this post

Amgen has completed construction of its first next-generation biomanufacturing facility, located in Singapore.

The new facility utilizes single-use bioreactors, disposable plastic containers, continuous purification processing and real-time quality analysis. It is expected to have the same production capacity as a conventional facility, but to use less energy and water and have lower solid waste and emission levels.

'At Amgen, we are reinventing what it means to manufacture biologic medicines," said Robert Bradway, Amgen's chairman and chief executive officer. 'Singapore is an ideal place to invest in such a pioneering facility because of its talented workforce and commitment to the biotechnology industry.'


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved